Published in Circulation on March 03, 2008
Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials (2009) 2.41
Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci U S A (2009) 1.91
Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc Natl Acad Sci U S A (2010) 1.87
Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. Tissue Eng Part A (2011) 1.66
Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. J Am Coll Cardiol (2012) 1.60
Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering. Tissue Eng Part A (2010) 1.39
Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms. Circ Res (2013) 1.33
Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges. Acta Biomater (2010) 1.33
Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices. J Cardiovasc Transl Res (2010) 1.28
Rapid biocompatibility analysis of materials via in vivo fluorescence imaging of mouse models. PLoS One (2010) 1.10
Injectable cardiac tissue engineering for the treatment of myocardial infarction. J Cell Mol Med (2010) 1.08
Influence of injectable hyaluronic acid hydrogel degradation behavior on infarction-induced ventricular remodeling. Biomacromolecules (2011) 1.08
Increased infarct wall thickness by a bio-inert material is insufficient to prevent negative left ventricular remodeling after myocardial infarction. PLoS One (2011) 1.06
Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor. Acta Biomater (2012) 1.05
Patching the heart: cardiac repair from within and outside. Circ Res (2013) 1.04
Biomimetic matrices for myocardial stabilization and stem cell transplantation. J Biomed Mater Res A (2010) 1.00
Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application. J Cell Mol Med (2010) 1.00
Thermally responsive injectable hydrogel incorporating methacrylate-polylactide for hydrolytic lability. Biomacromolecules (2010) 1.00
Modulation of material properties of a decellularized myocardial matrix scaffold. Macromol Biosci (2011) 0.97
Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts. J Cell Mol Med (2013) 0.96
Infarct restraint to limit adverse ventricular remodeling. J Cardiovasc Transl Res (2010) 0.96
Intramyocardial injection of platelet gel promotes endogenous repair and augments cardiac function in rats with myocardial infarction. J Am Coll Cardiol (2012) 0.95
Protein-engineered injectable hydrogel to improve retention of transplanted adipose-derived stem cells. Adv Healthc Mater (2012) 0.94
Cellular encapsulation enhances cardiac repair. J Am Heart Assoc (2013) 0.92
Engineering the heart: evaluation of conductive nanomaterials for improving implant integration and cardiac function. Sci Rep (2014) 0.92
Regenerating functional heart tissue for myocardial repair. Cell Mol Life Sci (2012) 0.92
Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure. JACC Heart Fail (2013) 0.92
Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors. Acta Biomater (2008) 0.92
Mechanisms of greater cardiomyocyte functions on conductive nanoengineered composites for cardiovascular application. Int J Nanomedicine (2012) 0.91
Bioactive scaffolds for engineering vascularized cardiac tissues. Macromol Biosci (2010) 0.88
Biomaterial based cardiac tissue engineering and its applications. Biomed Mater (2015) 0.88
In situ tissue regeneration through host stem cell recruitment. Exp Mol Med (2013) 0.87
Materials science and tissue engineering: repairing the heart. Mayo Clin Proc (2013) 0.87
Model systems for cardiovascular regenerative biology. Cold Spring Harb Perspect Med (2013) 0.87
Sensing the cardiac environment: exploiting cues for regeneration. J Cardiovasc Transl Res (2011) 0.86
Targeted injection of a biocomposite material alters macrophage and fibroblast phenotype and function following myocardial infarction: relation to left ventricular remodeling. J Pharmacol Exp Ther (2014) 0.85
Patient-to-patient variability in autologous pericardial matrix scaffolds for cardiac repair. J Cardiovasc Transl Res (2011) 0.85
Small intestinal submucosa gel as a potential scaffolding material for cardiac tissue engineering. Acta Biomater (2009) 0.84
Intramyocardial delivery of mesenchymal stem cell-seeded hydrogel preserves cardiac function and attenuates ventricular remodeling after myocardial infarction. PLoS One (2012) 0.84
Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model. Int J Nanomedicine (2011) 0.83
Calcium-alginate hydrogel-encapsulated fibroblasts provide sustained release of vascular endothelial growth factor. Tissue Eng Part A (2012) 0.83
Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review. J R Soc Interface (2015) 0.82
Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction. J Cardiovasc Transl Res (2011) 0.82
Intramyocardial Delivery of Notch Ligand-Containing Hydrogels Improves Cardiac Function and Angiogenesis Following Infarction. Tissue Eng Part A (2015) 0.82
Myocardial tissue elastic properties determined by atomic force microscopy after stromal cell-derived factor 1α angiogenic therapy for acute myocardial infarction in a murine model. J Thorac Cardiovasc Surg (2012) 0.82
Intramyocardial delivery of VEGF165 via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction. Heart Vessels (2015) 0.81
Injectable Hydrogels for Cardiac Tissue Repair after Myocardial Infarction. Adv Sci (Weinh) (2015) 0.81
Bioinjection treatment: effects of post-injection residual stress on left ventricular wall stress. J Biomech (2014) 0.81
Greater cardiomyocyte density on aligned compared with random carbon nanofibers in polymer composites. Int J Nanomedicine (2014) 0.81
MRI evaluation of injectable hyaluronic acid-based hydrogel therapy to limit ventricular remodeling after myocardial infarction. Biomaterials (2015) 0.81
Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering. Biomark Insights (2015) 0.80
Interfacing Sca-1(pos) mesenchymal stem cells with biocompatible scaffolds with different chemical composition and geometry. J Biomed Biotechnol (2009) 0.80
A degradable, bioactive, gelatinized alginate hydrogel to improve stem cell/growth factor delivery and facilitate healing after myocardial infarction. Med Hypotheses (2012) 0.80
Localized targeting of biomaterials following myocardial infarction: a foundation to build on. Trends Cardiovasc Med (2013) 0.80
Personalised computational cardiology: Patient-specific modelling in cardiac mechanics and biomaterial injection therapies for myocardial infarction. Heart Fail Rev (2016) 0.79
Stem cells for cardiac repair: an introduction. J Geriatr Cardiol (2013) 0.79
Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium. Fibrogenesis Tissue Repair (2008) 0.78
Mast cell inhibition attenuates myocardial damage, adverse remodeling, and dysfunction during fulminant myocarditis in the rat. J Cardiovasc Pharmacol Ther (2012) 0.78
Why Is Infarct Expansion Such an Elusive Therapeutic Target? J Cardiovasc Transl Res (2015) 0.78
Cardiac tissue engineering and regeneration using cell-based therapy. Stem Cells Cloning (2015) 0.78
Oxime cross-linked injectable hydrogels for catheter delivery. Adv Mater (2013) 0.78
Physiological Implications of Myocardial Scar Structure. Compr Physiol (2015) 0.78
Injectable Shear-Thinning Hydrogels for Minimally Invasive Delivery to Infarcted Myocardium to Limit Left Ventricular Remodeling. Circ Cardiovasc Interv (2016) 0.78
The role of tissue engineering and biomaterials in cardiac regenerative medicine. Can J Cardiol (2014) 0.78
Prognostic Value of Troponin I for Infarct Size to Improve Preclinical Myocardial Infarction Small Animal Models. Front Physiol (2015) 0.77
Bone marrow-derived multipotent stromal cells promote myocardial fibrosis and reverse remodeling of the left ventricle. Stem Cells Int (2015) 0.77
Cardiogenic differentiation of mesenchymal stem cells on elastomeric poly (glycerol sebacate)/collagen core/shell fibers. World J Cardiol (2013) 0.77
Making better scar: Emerging approaches for modifying mechanical and electrical properties following infarction and ablation. Prog Biophys Mol Biol (2015) 0.77
Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease. Int J Nanomedicine (2012) 0.77
A comparison of electrospun polymers reveals poly(3-hydroxybutyrate) fiber as a superior scaffold for cardiac repair. Stem Cells Dev (2014) 0.76
Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction. Biomaterials (2015) 0.76
The use of a novel cardiac bioreactor system in investigating fibroblast physiology and its perspectives. Organogenesis (2013) 0.76
In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin'. Stem Cell Res Ther (2015) 0.76
Improving Cell Engraftment in Cardiac Stem Cell Therapy. Stem Cells Int (2015) 0.76
Post-infarct biomaterials, left ventricular remodeling, and heart failure: is good good enough? Congest Heart Fail (2012) 0.76
Micro-structurally detailed model of a therapeutic hydrogel injectate in a rat biventricular cardiac geometry for computational simulations. Comput Methods Biomech Biomed Engin (2013) 0.75
How Biomaterials Can Influence Various Cell Types in the Repair and Regeneration of the Heart after Myocardial Infarction. Front Bioeng Biotechnol (2016) 0.75
3D Cell Culture in Alginate Hydrogels. Microarrays (Basel) (2015) 0.75
Cardiovascular Tissue Engineering: Preclinical Validation to Bedside Application. Physiology (Bethesda) (2016) 0.75
Intramyocardial injection of hydrogel with high interstitial spread does not impact action potential propagation. Acta Biomater (2015) 0.75
Tissue Engineering Strategies for Myocardial Regeneration: Acellular Versus Cellular Scaffolds? Tissue Eng Part B Rev (2016) 0.75
An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in rats. Int J Cardiol (2016) 0.75
Intramyocardial delivery of bFGF with a biodegradable and thermosensitive hydrogel improves angiogenesis and cardio-protection in infarcted myocardium. Exp Ther Med (2017) 0.75
Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med (2006) 8.74
Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation (2003) 5.20
Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation (2007) 2.99
Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells. Circulation (2009) 2.83
The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat (2007) 2.17
Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells. J Am Coll Cardiol (2012) 2.13
Functional class in patients with heart failure is associated with the development of diabetes. Am J Med (2003) 2.10
The role of ECG-gated MDCT in the evaluation of aortic and mitral mechanical valves: initial experience. AJR Am J Roentgenol (2008) 2.04
Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat (2005) 1.94
Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci U S A (2009) 1.91
Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart (2007) 1.86
Macrophage subpopulations are essential for infarct repair with and without stem cell therapy. J Am Coll Cardiol (2013) 1.82
Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart. Circulation (2006) 1.77
Long-term prognostic significance of left atrial volume in acute myocardial infarction. J Am Coll Cardiol (2004) 1.76
Prior exercise training improves the outcome of acute myocardial infarction in the rat. Heart structure, function, and gene expression. J Am Coll Cardiol (2005) 1.67
External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. J Am Coll Cardiol (2003) 1.63
Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study. JACC Cardiovasc Interv (2008) 1.63
Left atrial contractile function following a successful modified Maze procedure at surgery and the risk for subsequent thromboembolic stroke. J Am Coll Cardiol (2011) 1.62
Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proc Natl Acad Sci U S A (2011) 1.58
Monocyte and/or macrophage infiltration of heart after myocardial infarction: MR imaging by using T1-shortening liposomes. Radiology (2012) 1.58
Prevalence and clinical predictors of reverse remodeling in patients with dilated cardiomyopathy. Isr Med Assoc J (2014) 1.56
Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J Am Coll Cardiol (2009) 1.54
Effect of bundle branch block patterns on mortality in hospitalized patients with heart failure. Am J Cardiol (2008) 1.53
Fast track evaluation of patients with acute chest pain: experience in a large-scale chest pain unit in Israel. Isr Med Assoc J (2010) 1.51
Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol Ther (2004) 1.49
Reliability of visual assessment of global and segmental left ventricular function: a multicenter study by the Israeli Echocardiography Research Group. J Am Soc Echocardiogr (2010) 1.48
Alginate scaffold for organ culture of cryopreserved-thawed human ovarian cortical follicles. J Assist Reprod Genet (2011) 1.46
Pheochromocytoma: cyclic attacks of hypertension alternating with hypotension. Nat Clin Pract Cardiovasc Med (2008) 1.45
A new tool for automatic assessment of segmental wall motion based on longitudinal 2D strain: a multicenter study by the Israeli Echocardiography Research Group. Circ Cardiovasc Imaging (2009) 1.44
Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease. Circulation (2004) 1.42
Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A (2003) 1.41
Activation of the ERK1/2 cascade via pulsatile interstitial fluid flow promotes cardiac tissue assembly. Tissue Eng (2007) 1.35
Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol Bioeng (2002) 1.32
Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol (2008) 1.31
Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions. Biotechnol Bioeng (2004) 1.30
The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials (2009) 1.30
The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials (2011) 1.29
Human embryonic stem cells as an in vitro model for human vascular development and the induction of vascular differentiation. Lab Invest (2003) 1.28
Liver tissue engineering within alginate scaffolds: effects of cell-seeding density on hepatocyte viability, morphology, and function. Tissue Eng (2003) 1.26
A prospective national survey of management and clinical outcome of acute myocardial infarction in Israel, 2000. Isr Med Assoc J (2003) 1.24
Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol Bioeng (2004) 1.20
A novel perfusion bioreactor providing a homogenous milieu for tissue regeneration. Tissue Eng (2006) 1.20
Three-dimensional porous alginate scaffolds provide a conducive environment for generation of well-vascularized embryoid bodies from human embryonic stem cells. Biotechnol Bioeng (2004) 1.18
The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials (2008) 1.17
Integration of multiple cell-matrix interactions into alginate scaffolds for promoting cardiac tissue regeneration. Biomaterials (2010) 1.12
Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients. Eur Heart J (2005) 1.09
Tailoring the pore architecture in 3-D alginate scaffolds by controlling the freezing regime during fabrication. Biomaterials (2002) 1.09
Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium. Stem Cells (2005) 1.08
The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials (2008) 1.07
Vascular endothelial growth factor-releasing scaffolds enhance vascularization and engraftment of hepatocytes transplanted on liver lobes. Tissue Eng (2005) 1.07
Enhancing the drug metabolism activities of C3A--a human hepatocyte cell line--by tissue engineering within alginate scaffolds. Tissue Eng (2006) 1.07
Presenting symptoms, admission electrocardiogram, management, and prognosis in acute coronary syndromes: differences by age. Am J Geriatr Cardiol (2004) 1.03
A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development. FASEB J (2003) 1.02
Low-intensity ultrasound induces angiogenesis in rat hind-limb ischemia. Ultrasound Med Biol (2006) 1.01
Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med (2006) 1.01
Human macrophage regulation via interaction with cardiac adipose tissue-derived mesenchymal stromal cells. J Cardiovasc Pharmacol Ther (2012) 1.00
Endothelial progenitors: a new Tower of Babel? J Am Coll Cardiol (2006) 1.00
Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study. J Am Coll Cardiol (2002) 0.99
Electric field stimulation integrated into perfusion bioreactor for cardiac tissue engineering. Tissue Eng Part C Methods (2010) 0.99
Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease. Am Heart J (2007) 0.99
Cellular cardiomyoplasty of cardiac fibroblasts by adenoviral delivery of MyoD ex vivo: an unlimited source of cells for myocardial repair. Circulation (2002) 0.99
The effect of immobilized RGD peptide in macroporous alginate scaffolds on TGFbeta1-induced chondrogenesis of human mesenchymal stem cells. Biomaterials (2010) 0.99
The effect of immobilized RGD peptide in alginate scaffolds on cardiac tissue engineering. Acta Biomater (2010) 0.98
The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. Biomaterials (2010) 0.97